Literature DB >> 17643424

Three distinct stages of apoptotic nuclear condensation revealed by time-lapse imaging, biochemical and electron microscopy analysis of cell-free apoptosis.

Shigenobu Toné1, Kenji Sugimoto, Kazue Tanda, Taiji Suda, Kenzo Uehira, Hiroaki Kanouchi, Kumiko Samejima, Yohsuke Minatogawa, William C Earnshaw.   

Abstract

During apoptotic execution, chromatin undergoes a phase change from a heterogeneous, genetically active network to an inert highly condensed form that is fragmented and packaged into apoptotic bodies. We have previously used a cell-free system to examine the roles of caspases or other proteases in apoptotic chromatin condensation and nuclear disassembly. But so far, the role of DNase activity or ATP hydrolysis in this system has not yet been elucidated. Here, in order to better define the stages of nuclear disassembly in apoptosis, we have characterized the apoptotic condensation using a cell-free system and time-lapse imaging. We demonstrated that the population of nuclei undergoing apoptosis in vitro appears to follow a reproducible program of nuclear condensation, suggesting the existence of an ordered biochemical pathway. This enabled us to define three stages of apoptotic chromatin condensation: stage 1 ring condensation; stage 2 necklace condensation; and stage 3 nuclear collapse/disassembly. Electron microscopy revealed that neither chromatin nor detectable subnuclear structures were present inside the stage 1 ring-condensed structures. DNase activity was not essential for stage 1 ring condensation, which could occur in apoptotic extracts depleted of all detectable DNase activity. However, DNase(s) were required for stage 2 necklace condensation. Finally, we demonstrated that hydrolyzable ATP is required for stage 3 nuclear collapse/disassembly. This requirement for ATP hydrolysis further distinguished stage 2 from stage 3. Together, these experiments provide the first steps towards a systematic biochemical characterization of chromatin condensation during apoptosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643424      PMCID: PMC2705844          DOI: 10.1016/j.yexcr.2007.06.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  34 in total

1.  Modeling apoptotic chromatin condensation in normal cell nuclei. Requirement for intranuclear mobility and actin involvement.

Authors:  Piotr Widlak; Olena Palyvoda; Slawomir Kumala; William T Garrard
Journal:  J Biol Chem       Date:  2002-04-01       Impact factor: 5.157

2.  CAD/DFF40 nuclease is dispensable for high molecular weight DNA cleavage and stage I chromatin condensation in apoptosis.

Authors:  K Samejima; S Tone; W C Earnshaw
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

3.  Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death.

Authors:  N Joza; S A Susin; E Daugas; W L Stanford; S K Cho; C Y Li; T Sasaki; A J Elia; H Y Cheng; L Ravagnan; K F Ferri; N Zamzami; A Wakeham; R Hakem; H Yoshida; Y Y Kong; T W Mak; J C Zúñiga-Pflücker; G Kroemer; J M Penninger
Journal:  Nature       Date:  2001-03-29       Impact factor: 49.962

Review 4.  Apoptosis-inducing factor: vital and lethal.

Authors:  Nazanine Modjtahedi; Fabrizio Giordanetto; Frank Madeo; Guido Kroemer
Journal:  Trends Cell Biol       Date:  2006-04-18       Impact factor: 20.808

5.  Caspase-6 gene disruption reveals a requirement for lamin A cleavage in apoptotic chromatin condensation.

Authors:  Sandrine Ruchaud; Nadia Korfali; Pascal Villa; Timothy J Kottke; Colin Dingwall; Scott H Kaufmann; William C Earnshaw
Journal:  EMBO J       Date:  2002-04-15       Impact factor: 11.598

6.  Centromere/kinetochore localization of human centromere protein A (CENP-A) exogenously expressed as a fusion to green fluorescent protein.

Authors:  K Sugimoto; R Fukuda; M Himeno
Journal:  Cell Struct Funct       Date:  2000-08       Impact factor: 2.212

7.  Molecular behavior in living mitotic cells of human centromere heterochromatin protein HPLalpha ectopically expressed as a fusion to red fluorescent protein.

Authors:  K Sugimoto; H Tasaka; M Dotsu
Journal:  Cell Struct Funct       Date:  2001-12       Impact factor: 2.212

8.  Condensin is required for nonhistone protein assembly and structural integrity of vertebrate mitotic chromosomes.

Authors:  Damien F Hudson; Paola Vagnarelli; Reto Gassmann; William C Earnshaw
Journal:  Dev Cell       Date:  2003-08       Impact factor: 12.270

9.  High molecular weight DNA fragments are processed by caspase sensitive or caspase independent pathways in cultures of cerebellar granule neurons.

Authors:  Hege Holte Slagsvold; Carola Maria Rosseland; Chris Jacobs; Erica Khuong; Nina Kristoffersen; Mona Gaarder; Asa Birgitta Fallgren; Henrik Sverre Huitfeldt; Ragnhild Elisabeth Paulsen
Journal:  Brain Res       Date:  2003-09-12       Impact factor: 3.252

10.  Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase.

Authors:  Wang L Cheung; Kozo Ajiro; Kumiko Samejima; Malgorzata Kloc; Peter Cheung; Craig A Mizzen; Alexander Beeser; Laurence D Etkin; Jonathan Chernoff; William C Earnshaw; C David Allis
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

View more
  53 in total

1.  High-content assays for hepatotoxicity using induced pluripotent stem cell-derived cells.

Authors:  Oksana Sirenko; Jayne Hesley; Ivan Rusyn; Evan F Cromwell
Journal:  Assay Drug Dev Technol       Date:  2013-11-14       Impact factor: 1.738

2.  Clostridium perfringens iota-toxin b induces rapid cell necrosis.

Authors:  Masahiro Nagahama; Mariko Umezaki; Masataka Oda; Keiko Kobayashi; Shigenobu Tone; Taiji Suda; Kazumi Ishidoh; Jun Sakurai
Journal:  Infect Immun       Date:  2011-09-12       Impact factor: 3.441

3.  Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.

Authors:  Alexandra H Dudek; Florian Pfaff; Hardin Bolte; Collins Waguia Kontchou; Martin Schwemmle
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

4.  Nutrient limitation affects presynaptic structures through dissociable Bassoon autophagic degradation and impaired vesicle release.

Authors:  Alberto Catanese; Débora Garrido; Paul Walther; Francesco Roselli; Tobias M Boeckers
Journal:  J Cereb Blood Flow Metab       Date:  2018-07-04       Impact factor: 6.200

5.  Regulation of nuclear envelope permeability in cell death and survival.

Authors:  Christine Strasser; Patricia Grote; Karin Schäuble; Magdalena Ganz; Elisa Ferrando-May
Journal:  Nucleus       Date:  2012-08-28       Impact factor: 4.197

Review 6.  Predicting the fate of eDNA in the environment and implications for studying biodiversity.

Authors:  Jori B Harrison; Jennifer M Sunday; Sean M Rogers
Journal:  Proc Biol Sci       Date:  2019-11-20       Impact factor: 5.349

7.  Enhanced in Vitro Anti-Tumor Activity of 5-Azacytidine by Entrapment into Solid Lipid Nanoparticles.

Authors:  Farhad Jahanfar; Akbar Hasani; Dariush Shanebandi; Mohammad Rahmati; Hamed Hamishehkar
Journal:  Adv Pharm Bull       Date:  2016-09-25

8.  The role of the granuloma in expansion and dissemination of early tuberculous infection.

Authors:  J Muse Davis; Lalita Ramakrishnan
Journal:  Cell       Date:  2009-01-09       Impact factor: 41.582

9.  The natural product mensacarcin induces mitochondrial toxicity and apoptosis in melanoma cells.

Authors:  Birte Plitzko; Elizabeth N Kaweesa; Sandra Loesgen
Journal:  J Biol Chem       Date:  2017-10-26       Impact factor: 5.157

10.  Preanalytical Variables for the Genomic Assessment of the Cellular and Acellular Fractions of the Liquid Biopsy in a Cohort of Breast Cancer Patients.

Authors:  Stephanie N Shishido; Lisa Welter; Mariam Rodriguez-Lee; Anand Kolatkar; Liya Xu; Carmen Ruiz; Anna S Gerdtsson; Sara Restrepo-Vassalli; Anders Carlsson; Joe Larsen; Emily J Greenspan; E Shelley Hwang; Kathryn R Waitman; Jorge Nieva; Kelly Bethel; James Hicks; Peter Kuhn
Journal:  J Mol Diagn       Date:  2020-01-22       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.